|Chemical and physical data|
|Molar mass||383.45 g/mol g·mol−1|
|3D model (JSmol)|
Anagliptin (INN; trade name Suiny) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins".
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|